ArticleFrontiers in public health2026
HEMS and the challenges of an aging population: a nationwide study of interventions.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: We aimed to characterize HEMS missions in Poland in 2015-2024 among patients aged ≥65 years and to describe unadjusted associations between age strata and escalation of advanced interventions as well as on-scene mortality after HEMS arrival. Materials and methods: We performed a retrospective analysis of the national HEMS registry in 2015-2024, including patients aged ≥65 years. Diagnoses were grouped into five clinical domains. The primary endpoint was on-scene mortality after HEMS arrival (death on scene recorded as mission outcome left on scene - death); dispatches coded as dead on arrival (DOA) were excluded. Secondary endpoints were use of advanced airway management, Prehospital Emergency Anaesthesia (PHEA), and mission outcome. We used univariable logistic regression to estimate unadjusted odds ratios (OR) with 95% confidence intervals (95% CI) for each exposure - outcome association. Results: Among 30,075 missions, neurological (42.8%) and cardiovascular (31.0%) conditions predominated. Most missions occurred in daytime (92.5%) and in rural areas (57.1%). Compared with the 65-74 group, patients aged ≥75 years less often required escalation to advanced interventions, including intubation (OR 0.71; 95% CI 0.66-0.76), PHEA-consistent sedation (0.76; 0.71-0.80), and neuromuscular blockade (0.66; 0.61-0.72). They also had lower on-scene mortality (0.75; 0.69-0.83). The highest on-scene mortality risk occurred in the cardiovascular domain (OR 6.20; 4.93-7.80). Conclusion: In Poland, HEMS provides critical access to rapid, advanced prehospital care for older adults, especially in rural regions. The observed associations highlight age-stratified differences in intervention intensity and on-scene mortality; however, results are unadjusted and may be influenced by differences in case-mix, illness severity, and treatment limitation decisions. Frailty was not measured in the registry; therefore, any interpretation in terms of frailty should be considered hypothesis-generating and requires prospective studies incorporating standardized frailty instruments (e.g., CFS).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.